First international consensus on the diagnosis and management of fibromuscular dysplasia

HL Gornik, A Persu, D Adlam, LS Aparicio… - Vascular …, 2019 - journals.sagepub.com
This article is a comprehensive document on the diagnosis and management of
fibromuscular dysplasia (FMD), which was commissioned by the working group …

Revisiting fibromuscular dysplasia: rationale of the European fibromuscular dysplasia initiative

A Persu, P Van der Niepen, E Touzé, S Gevaert… - …, 2016 - Am Heart Assoc
Persu et al Fibromuscular Dysplasia Deserves to Be Revisited 833 lines, in the CORAL trial
(Cardiovascular Outcomes in Renal Atherosclerotic Lesions), where FMD was an exclusion …

The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)—clinical phenotypes and their predictors based on a cohort of 1000 patients

M Pappaccogli, S Di Monaco… - Cardiovascular …, 2021 - academic.oup.com
Abstract Aims Since December 2015, the European/International Fibromuscular Dysplasia
(FMD) Registry enrolled 1022 patients from 22 countries. We present their characteristics …

National information system for rare diseases with an approach to data architecture: A systematic review

S Derayeh, A Kazemi, R Rabiei, A Hosseini… - Intractable & Rare …, 2018 - jstage.jst.go.jp
The study aims to systematically review literature on the rare diseases information system to
identify architecture of this system from a data perspective. The search for relevant English …

Renovascular hypertension

A Persu, PV der Niepen - Disorders of Blood Pressure Regulation …, 2018 - Springer
Renovascular hypertension (RVH) is the most common curable cause of elevated blood
pressure (BP)(Elliott, J Clin Hypertens 10: 522–533, 2008). During the last decades, more …